Publication: BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis
1
Issued Date
2015-01-01
Resource Type
ISSN
15137368
Other identifier(s)
2-s2.0-84928625049
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Cancer Prevention. Vol.16, No.7 (2015), 2807-2811
Suggested Citation
Pirut Tong-ngam, Sittiruk Roytrakul, Hathaitip Sritanaudomchai BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis. Asian Pacific Journal of Cancer Prevention. Vol.16, No.7 (2015), 2807-2811. doi:10.7314/APJCP.2015.16.7.2807 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/35592
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis
Abstract
Scorpion venom peptides recently have attracted attention as alternative chemotherapeutic agents that may overcome the limitations of current drugs, providing specific cytotoxicity for cancer cells with an ability to bypass multidrug-resistance mechanisms, additive effects in combination therapy and safety. In the present study, BmKn-2 scorpion venom peptide and its derivatives were chosen for assessment of anticancer activities. BmKn-2 was identified as the most effective against human oral squamous cells carcinoma cell line (HSC-4) by screening assays with an IC50 value of 29 μg/ml. The BmKn-2 peptide killed HSC-4 cells through induction of apoptosis, as confirmed by phase contrast microscopy and RT-PCR techniques. Typical morphological features of apoptosis including cell shrinkage and rounding characteristics were observed in treated HSC-4 cells. The results were further confirmed by increased expression of pro-apoptotic genes such as caspase-3, -7, and -9 but decrease mRNA level of anti-apoptotic BCL-2 in BmKn-2 treated cells, as determined by RT-PCR assay. In summary, the BmKn-2 scorpion venom peptide demonstrates specific membrane binding, growth inhibition and apoptogenic activity against human oral cancer cells.